AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board
“There’s an electricity of discovery here like Genentech and Amgen,” said Dr. Herman. “AbSci’s ability to fold proteins is an innovative art form. This technology enables more efficient manufacturing, which will bring down the price of drugs.”
read moreAbSci Appoints William F. Bennett, PhD to Scientific Advisory Board
“The culture here reminds me of Genentech in the early days. It’s an honor to join the team as a Scientific Advisor,” said Dr. Bennett. “AbSci’s technology is a quantum improvement in bacterial expression systems.”
read more
AbSci at 36th JP Morgan Conference January 8th – 11th.
AbSci Appoints Fred Larimore, PhD to Scientific Advisory Board
AbSci announced today the appointment of Fred Larimore, PhD to AbSci’s Scientific Advisory Board. Dr. Larimore brings over 30 years of experience in biopharmaceutical manufacturing and process development at leading pharmaceutical companies …
read more
2017: A Big Year for AbSci – Growth and Continued Expansion
AbSci, a global leader in breakthrough biomanufacturing technologies, today announced that it is further expanding its offices and laboratory facilities. “We’ve seen a significant increase in partnership deal flow, which is a testament to the innovation and quality of work performed by our scientists,” said CEO and Founder, Sean McClain …
read more
AbSci named PBJ’s Small Business Innovation Award Winner for 2017
AbSci to be named one of Portland's most innovative companies of the year. The awards ceremony will take place at Portland's Hilton Hotel Wednesday, November 1st. You can read more about the event here....
read more
AbSci wins 2017 OEN ‘Start-up’ Award
Oct 26, 2017. Companies in biotech, security software and cloud management were among the big winners Wednesday night at the 24th Annual OEN Tom Holce Entrepreneurship Awards.Hundreds of Oregon business community members turned out for the event at the Oregon...
read more
AbSci Raises Series B Financing
AbSci, a global leader in breakthrough biomanufacturing technologies, announced that it closed its Series B financing round for an undisclosed amount. The round includes previous investors along with several new investors …
read more
US Patent Granted for SoluPro™ Technology
Vancouver, WA – April 11, 2017 United States Patent No. 9,617,335 was issued today to AbSci, an industry leader in biomanufacturing innovation, for its SoluPro™ protein expression system, which produces complex therapeutic proteins at unparalleled yield and throughput...
read more
AbSci Receives European Patent on its SoluPro™ Expression Platform
AbSci a global leader in biomanufacturing technologies, was granted a European regional patent today for its SoluPro™ protein production technology. “Many years of discovery went into developing the SoluPro™ expression platform. The SoluPro™ technology provides a revolutionary solution to one of biomanufacturing’s ongoing challenges …
read more